Novo Nordisk’s Ozempic takes on Lilly’s Trulicity in DTC showdown
The two diabetes rivals air competing TV spots as they compete for GLP-1 supremacy.
Commercial
Q&A: Matt McNally on the road ahead for Outcome Health and the state of the POC union
Matt McNally, CEO of Outcome Health, shares his thoughts on post-controversy Outcome Health and the overall state of the point-of-care union.
Media buyers form group to advance standards in POC
Among the group’s members are media agencies that had pulled healthcare ad spend from the POC channel in the wake of a scandal 10 months ago.
POC community makes good on promises of transparency and accountability
After a scandal with one of point of care’s biggest players, we examine how the community is living up to its promise of greater transparency.
Familiar names highlight Pfizer’s Q2
Historical big earners once again performed for Pfizer in Q2, while Ibrance broke the $1 billion barrier.
Study: 77% of young people exposed to Truth ads don’t plan to smoke
The Truth Initiative surveyed 9,000 young people to determine whether its campaign was really working.
Pharma’s med-ed backing rises for fourth straight year
Data on medical education spending show a continued increase in investment from the pharma and medical device industries.
Stelara highlights J&J’s Q2 performance
The company posted a sales increase of 10.6% in the second quarter.
Allergan gets candid about birth control in Lo Loestrin Fe campaign
The campaign is appearing in millennial- and women-focused outlets such as Refinery29, Instagram, Bravo!, HGTV, and Cosmopolitan.
The caregiver’s journey is a highly personal one. A study examined their role in treatment decisions
Caregivers are intimately involved in patient health, and that includes deciding on treatments, a new study suggests.
Want to read more?
Please login or register first to view this content.
